Nabil F. Saba
Experienced in Basal Cell Skin Cancer

Dr. Nabil F. Saba

Oncology
Emory health
Winship Cancer Institute At Emory Midtown
36 Linden Avenue Northeast, 
Atlanta, GA 
Offers Telehealth
36 Years of Experience
Experienced in Basal Cell Skin Cancer
Emory health
Winship Cancer Institute At Emory Midtown
36 Linden Avenue Northeast, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nabil Saba is an Oncologist in Atlanta, Georgia. Dr. Saba has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Glossectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 235 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Basal Cell Skin Cancer.

Graduate Institution
American University Of Beirut, 1990.0
Residency
Faulkner Hospital
Specialties
Oncology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine, 1997
Fellowships
Princess Margaret Hosp-CAN
Brown University
Hospital Affiliations
Emory University Hospital Midtown
Emory University Hospital
Saint Joseph's Hospital Of Atlanta, Inc
Languages Spoken
English
Arabic
French
Gender
Male
Awards
Atlanta Magazine's "Top Doctors", 2005, 2016-2020
MilliPub Club Award, Emory University School of Medicine, 2020
Director's Service Award, National Cancer Institute, 2019
Outstanding reviewer for journal, Cancer, 2017
Castle Connolly Top Doctors, 2011 and 2014
Distinguished Doctor, Expert Network, 2015

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Winship Cancer Institute at Emory Midtown
36 Linden Avenue Northeast, Atlanta, GA 30308
Call: 404-778-0278

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Suspended
Publish Date: December 17, 2025
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Suspended
Publish Date: December 17, 2025
Intervention Type: Biological, Drug, Procedure, Radiation
Study Drugs: Carboplatin, Ipilimumab, Nivolumab, Paclitaxel
Study Phase: Phase 2/Phase 3
A Phase 1/2, Open-Label, Study to Evaluate the Safety and Anti-Tumor Activity of FS118, a LAG-3/PD-L1 Bispecific Antibody, as a Monotherapy and in Combination With Paclitaxel, in Patients With Advanced Malignancies
A Phase 1/2, Open-Label, Study to Evaluate the Safety and Anti-Tumor Activity of FS118, a LAG-3/PD-L1 Bispecific Antibody, as a Monotherapy and in Combination With Paclitaxel, in Patients With Advanced Malignancies
Enrollment Status: Terminated
Publish Date: July 01, 2025
Intervention Type: Drug
Study Drug: FS118
Study Phase: Phase 1/Phase 2
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (PRESERVE-001)
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (PRESERVE-001)
Enrollment Status: Active_not_recruiting
Publish Date: May 23, 2025
Intervention Type: Drug
Study Drugs: ONC-392, Pembrolizumab
Study Phase: Phase 1/Phase 2
A Phase1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line or CUE-101 Combination Therapy With Pembrolizumab in First Line Patients With HPV16+ Recurrent/Metastatic HNSCC
A Phase1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line or CUE-101 Combination Therapy With Pembrolizumab in First Line Patients With HPV16+ Recurrent/Metastatic HNSCC
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Drug
Study Drugs: CUE-101, Pembrolizumab
Study Phase: Phase 1
Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)
Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Cetuximab
Study Phase: Phase 2
A Phase II Trial of Pembrolizumab and Cabozantinib in Patients With RM SCCHN
A Phase II Trial of Pembrolizumab and Cabozantinib in Patients With RM SCCHN
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2025
Intervention Type: Drug, Biological
Study Drugs: Cabozantinib, Pembrolizumab
Study Phase: Phase 2
Phase II Study of IMRT Re-Irradiation With Concurrent/Adjuvant Nivolumab in Patients With Locoregionally Recurrent or Second Primary Squamous Cell Cancer of the Head and Neck
Phase II Study of IMRT Re-Irradiation With Concurrent/Adjuvant Nivolumab in Patients With Locoregionally Recurrent or Second Primary Squamous Cell Cancer of the Head and Neck
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Biological, Radiation
Study Drug: Nivolumab
Study Phase: Phase 2
View 7 Less Clinical Trials

235 Total Publications

Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Journal: Nature medicine
Published: July 02, 2024
View All 235 Publications
Similar Doctors
Ragini R. Kudchadkar
Elite in Basal Cell Skin Cancer
Dr. Ragini R. Kudchadkar
Oncology
Elite in Basal Cell Skin Cancer
Dr. Ragini R. Kudchadkar
Oncology
1365 Clifton Rd Ne, 2nd Floor, 
Atlanta, GA 
 (4.1 miles away)
404-778-2407
Languages Spoken:
English
See accepted insurances

Ragini Kudchadkar is an Oncologist in Atlanta, Georgia. Dr. Kudchadkar is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, and Melanoma of the Eye.

Experienced in Basal Cell Skin Cancer
Dr. Melvin R. Moore
Hematology Oncology | Oncology
Experienced in Basal Cell Skin Cancer
Dr. Melvin R. Moore
Hematology Oncology | Oncology
2712 Lawrenceville Hwy, 
Decatur, GA 
 (8.2 miles away)
770-496-5555
Languages Spoken:
English
See accepted insurances

Melvin Moore is a Hematologist Oncology specialist and an Oncologist in Decatur, Georgia. Dr. Moore is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Laryngeal Cancer.

Experienced in Basal Cell Skin Cancer
Dr. Andre M. Kallab
Hematology Oncology | Hematology | Oncology
Experienced in Basal Cell Skin Cancer
Dr. Andre M. Kallab
Hematology Oncology | Hematology | Oncology

Northeast Georgia Diagnostic Associates And Clinic, LLC

1240 Jesse Jewell Pkwy Se, Suite 500, 
Gainesville, GA 
 (49.5 miles away)
770-536-9864
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Andre Kallab is a Hematologist Oncology specialist and a Hematologist in Gainesville, Georgia. Dr. Kallab is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Tissue Biopsy. Dr. Kallab is currently accepting new patients.

VIEW MORE BASAL CELL SKIN CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Saba's expertise for a condition
ConditionClose
  • Elite
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
    Dr. Saba is
    Elite
    . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
    See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
  • Laryngeal Cancer
    Dr. Saba is
    Elite
    . Learn about Laryngeal Cancer.
    See more Laryngeal Cancer experts
  • Throat Cancer
    Dr. Saba is
    Elite
    . Learn about Throat Cancer.
    See more Throat Cancer experts
  • Distinguished
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Saba is
    Distinguished
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • Adenoid Cystic Carcinoma
    Dr. Saba is
    Distinguished
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • Bone Tumor
    Dr. Saba is
    Distinguished
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Epithelial-Myoepithelial Carcinoma
    Dr. Saba is
    Distinguished
    . Learn about Epithelial-Myoepithelial Carcinoma.
    See more Epithelial-Myoepithelial Carcinoma experts
  • Nasopharyngeal Carcinoma
    Dr. Saba is
    Distinguished
    . Learn about Nasopharyngeal Carcinoma.
    See more Nasopharyngeal Carcinoma experts
  • Oral Squamous Cell Carcinoma
    Dr. Saba is
    Distinguished
    . Learn about Oral Squamous Cell Carcinoma.
    See more Oral Squamous Cell Carcinoma experts
View All 10 Distinguished Conditions
  • Advanced
  • Anaplastic Thyroid Cancer
    Dr. Saba is
    Advanced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Ewing Sarcoma
    Dr. Saba is
    Advanced
    . Learn about Ewing Sarcoma.
    See more Ewing Sarcoma experts
  • Familial Pancreatic Cancer
    Dr. Saba is
    Advanced
    . Learn about Familial Pancreatic Cancer.
    See more Familial Pancreatic Cancer experts
  • Follicular Thyroid Cancer
    Dr. Saba is
    Advanced
    . Learn about Follicular Thyroid Cancer.
    See more Follicular Thyroid Cancer experts
  • Glioma
    Dr. Saba is
    Advanced
    . Learn about Glioma.
    See more Glioma experts
  • Lung Cancer
    Dr. Saba is
    Advanced
    . Learn about Lung Cancer.
    See more Lung Cancer experts
View All 12 Advanced Conditions
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Saba is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Saba is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Alveolar Soft Part Sarcoma
    Dr. Saba is
    Experienced
    . Learn about Alveolar Soft Part Sarcoma.
    See more Alveolar Soft Part Sarcoma experts
  • Angiosarcoma
    Dr. Saba is
    Experienced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Aseptic and Alopecic Nodules of Scalp (AANS)
    Dr. Saba is
    Experienced
    . Learn about Aseptic and Alopecic Nodules of Scalp (AANS).
    See more Aseptic and Alopecic Nodules of Scalp (AANS) experts
  • Basal Cell Skin Cancer
    Dr. Saba is
    Experienced
    . Learn about Basal Cell Skin Cancer.
    See more Basal Cell Skin Cancer experts
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.